South Korea · Series B startup

Who invested in MediMabBio

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$18Mraised across 1 round since 2025, from 1 source

Latest round
Series B, $18MOct 2025
Investors
3
See who backed them

The rounds

  1. Oct 2025

Founders and team

From MediMabBio's own website: 3 on the team.

  • Eunjoo KimCFO
  • Eunok KangCOO
  • Kwanghyun KimCFO

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about MediMabBio

Who invested in MediMabBio?

MediMabBio's investors include Korea Tech Incubator Program For Startup, KB Investment and Smilegate Investment.

How much has MediMabBio raised?

MediMabBio has raised $18M across 1 round since 2025.

When did MediMabBio last raise?

MediMabBio's most recent round was a Series B of $18M in Oct 2025.

What was MediMabBio's biggest round?

Its most recent round, $18M in Oct 2025, is also its largest on record.

Who backed MediMabBio first?

MediMabBio's first round on record, in Oct 2025, was backed by Korea Tech Incubator Program For Startup, KB Investment and Smilegate Investment.

What stage is MediMabBio at?

MediMabBio's latest named round is a Series B, in Oct 2025.

Where is MediMabBio based?

MediMabBio is based in South Korea.

Companies like MediMabBio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.